Home›Stock Screener›Invicta Diagnostic

Invicta Diagnostic Share Price Today | Stock Price & Invicta Diagnostic Share Screener

INVICTA Healthcare Services

Track the current Invicta Diagnostic share price and stock price live with TickJournal's free stock screener. Track INVICTA market cap trends to gauge the company's total market size. Use the Invicta Diagnostic stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Invicta Diagnostic opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Invicta Diagnostic Market Cap ₹97.68 Cr.
INVICTA P/E Ratio (TTM) -
Invicta Diagnostic P/B Ratio 1.99
EPS (TTM) ₹4.90
Dividend Yield -
Debt to Equity 0.11
INVICTA 52 Week High -
Invicta Diagnostic 52 Week Low -
Operating Margin -
Profit Margin -
INVICTA Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹60.00
Total Equity ₹50.00

Invicta Diagnostic Share Price Chart

Track the current stock price of Invicta Diagnostic with an interactive chart. Analyse INVICTA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Invicta Diagnostic stock quote in one place.

Invicta Diagnostic Company Profile - Fundamental Screener

Screen Invicta Diagnostic company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INVICTA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE0XJ501010.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE0XJ501010

Invicta Diagnostic Balance Sheet Screener

Screen INVICTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹60, up from ₹21 in 2025.

Latest statistics put total assets at ₹60 and shareholder funds at ₹50, with a leverage ratio of 0.11.

Item 2026 2025 2024

Assets

Total Assets 60 21 16
Current Assets 0 0 0
Fixed Assets 19 10 12

Liabilities

Total Liabilities 0 0 0
Current Liabilities 3 5 3
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 50 14 11
Share Capital 13 8 0
Reserves & Surplus 37 5 12

Invicta Diagnostic Income Statement Screener - Profit & Revenue Analysis

Screen Invicta Diagnostic income statement and profit fundamentals. Analyze INVICTA quarterly results. Invicta Diagnostic reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹33 and net profit of ₹5.

Item None-None 2026-March 2025-March 2024-March

Revenue and Expenses

Revenue 0 33 30 8
Expenses 0 23 21 5

Operating Costs and Margins

EBITDA 0 11 9 4
Operating Profit % 0.00% 30.00% 31.00% 43.00%
Depreciation 0 3 3 1
Interest 0 0 0 0

Profit and Earnings

Profit Before Tax 0 7 7 3
Tax 0 2 2 0
Net Profit 0 5 5 3
EPS 0.00 4.90 5.86 3.19

Invicta Diagnostic Cash Flow Screener - Liquidity Fundamentals

Screen INVICTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹3, and net cash flow was an inflow of ₹20.

Over the same period, investing activities used ₹14 and financing activities provided ₹31.

Item 2026-March 2025-March 2024-March

Cash from Operations and Investing

Operating Activities 3 7 4
Investing Activities -14 -5 -10

Financing and Net Cash

Financing Activities 31 -1 7
Net Cash Flow 20 1 1

Invicta Diagnostic Shareholding Pattern Screener

See Invicta Diagnostic shareholding pattern with promoter, FII, and DII holdings. Check Invicta Diagnostic promoter holding and ownership changes for INVICTA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 66.70%, foreign institutions 4.20%, domestic institutions 4.30% and the public 18.71%, spread across 411 shareholders.

The shareholder count was 411 in 2026-Mar, compared with 410 in 2026-Sept.

Item 2026-Mar 2026-Sept 2025-Nov 2025-Dec 2024-Aug

Promoter Holding

Promoter Holding 66.70% 66.70% 90.52% 66.70% 100.00%

Institutional Investors

FII Holding 4.20% 1.54% 0.00% 0.94% 0.00%
DII Holding 4.30% 4.25% 0.00% 10.22% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 18.71% 21.14% 0.00% 18.49% 0.00%
Other Holding 6.10% 6.38% 9.48% 3.66% 0.00%
Shareholder Count 411 410 34 34 14

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Invicta Diagnostic. Invicta Diagnostic dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Invicta Diagnostic.

Invicta Diagnostic Stock Index Membership - Nifty & Sensex

See which indices include Invicta Diagnostic stock. Check INVICTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Invicta Diagnostic is not part of any tracked indices.
Only major market indices are tracked in our system.

Invicta Diagnostic Market Events Screener - Corporate Actions

Get Invicta Diagnostic corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Invicta Diagnostic stock events that may affect INVICTA share price, along with derivatives, futures and options activity and sector gainers.

4 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Quarterly Result Announcement dated August 25, 2026 and Quarterly Result Announcement dated May 18, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA 20.12%
2026-08-25 2026-08-25 Quarterly Result Announcement NA 0.00%
2026-05-18 2026-05-18 Quarterly Result Announcement NA 3.95%
2026-04-17 2026-04-17 Extraordinary General Meeting NA 2.74%

Invicta Diagnostic Competitors Screener - Peer Stocks Comparison

Screen INVICTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,832 53.50 25,420 15.58% 2,003 64.60
Max Healthcare Institute 99,555 72.60 8,536 18.82% 1,442 73.26
Manipal Health Enterprises 90,610 105.70 10,521 25.80% 917 55.90
Aster DM Quality Care 63,719 114.20 4,769 11.25% 427 55.32
Fortis Healthcare 59,910 57.30 9,179 16.93% 1,064 53.33
Narayana Hrudayalaya 38,651 45.30 7,996 43.43% 811 58.72
Global Health 38,626 63.30 4,509 19.56% 554 62.81
Dr. Lal Path Labs 32,989 56.50 2,864 12.11% 510 51.82
Krishna Institute of Medical Sciences 31,878 163.70 3,931 28.16% 242 62.11
Syngene International 17,552 94.20 3,809 2.56% 317 61.95

Invicta Diagnostic Company Announcements - News & Reports Screener

Screen INVICTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 1.99. Market capitalisation stands at ₹97.68 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 21, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 3 cash flow years and 5 shareholding periods. Information is provided for research and is not investment advice.